P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS

Bibliographic Details
Main Authors: Zachary Zaroogian, Elżbieta Adamczyk, Adrianna Moszyńska, Marta Obacz, Urszula Pakulska, Benjamin Durham, Milena Mazan, Shoron Mowla, Katarzyna Wnęk, Amritha Varshini Hanasoge Somasundara, Beata Barczuk, Aniela Gołas, Ross Levine, Tomasz Rzymski, Raajit K Rampal
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d
_version_ 1797279886843314176
author Zachary Zaroogian
Elżbieta Adamczyk
Adrianna Moszyńska
Marta Obacz
Urszula Pakulska
Benjamin Durham
Milena Mazan
Shoron Mowla
Katarzyna Wnęk
Amritha Varshini Hanasoge Somasundara
Beata Barczuk
Aniela Gołas
Ross Levine
Tomasz Rzymski
Raajit K Rampal
author_facet Zachary Zaroogian
Elżbieta Adamczyk
Adrianna Moszyńska
Marta Obacz
Urszula Pakulska
Benjamin Durham
Milena Mazan
Shoron Mowla
Katarzyna Wnęk
Amritha Varshini Hanasoge Somasundara
Beata Barczuk
Aniela Gołas
Ross Levine
Tomasz Rzymski
Raajit K Rampal
author_sort Zachary Zaroogian
collection DOAJ
first_indexed 2024-03-07T16:32:27Z
format Article
id doaj.art-512f19d4f82d4000871ea3e889e115ae
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:32:27Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-512f19d4f82d4000871ea3e889e115ae2024-03-03T10:07:35ZengWileyHemaSphere2572-92412023-08-017e133428d10.1097/01.HS9.0000970848.13342.8d202308003-00886P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMSZachary Zaroogian0Elżbieta Adamczyk1Adrianna Moszyńska2Marta Obacz3Urszula Pakulska4Benjamin Durham5Milena Mazan6Shoron Mowla7Katarzyna Wnęk8Amritha Varshini Hanasoge Somasundara9Beata Barczuk10Aniela Gołas11Ross Levine12Tomasz Rzymski13Raajit K Rampal141 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d
spellingShingle Zachary Zaroogian
Elżbieta Adamczyk
Adrianna Moszyńska
Marta Obacz
Urszula Pakulska
Benjamin Durham
Milena Mazan
Shoron Mowla
Katarzyna Wnęk
Amritha Varshini Hanasoge Somasundara
Beata Barczuk
Aniela Gołas
Ross Levine
Tomasz Rzymski
Raajit K Rampal
P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
HemaSphere
title P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
title_full P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
title_fullStr P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
title_full_unstemmed P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
title_short P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
title_sort p986 combination jak1 2 and cdk8 19 inhibition demonstrates enhanced efficacy in myeloproliferative neoplasms
url http://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d
work_keys_str_mv AT zacharyzaroogian p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT elzbietaadamczyk p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT adriannamoszynska p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT martaobacz p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT urszulapakulska p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT benjamindurham p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT milenamazan p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT shoronmowla p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT katarzynawnek p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT amrithavarshinihanasogesomasundara p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT beatabarczuk p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT anielagołas p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT rosslevine p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT tomaszrzymski p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms
AT raajitkrampal p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms